Subcortical brain iron deposition in individuals with schizophrenia.


Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
07 2022
Historique:
received: 06 12 2021
revised: 01 04 2022
accepted: 18 04 2022
pubmed: 7 5 2022
medline: 18 6 2022
entrez: 6 5 2022
Statut: ppublish

Résumé

Subcortical structures play a critical role the pathophysiology and treatment of schizophrenia (SZ), yet underlying neurophysiological processes, in vivo, remain largely unexplored. Brain tissue iron, which can be measured with magnetic resonance-based methods, is a crucial component of a variety of neuronal functions including neurotransmitter synthesis. Here we used a proxy measure of tissue iron to examine basal ganglia and thalamic structures in an adult cohort of individuals with chronic SZ. A publicly available dataset of 72 individuals with SZ between ages 18 and 65, and a matched sample of 74 healthy control (HC) participants were included. A novel method that calculated the inverse-normalized T2*-weighted contrast (1/nT2*) was used to estimate brain iron within the basal ganglia and thalamus. Between group, age- and sex-related differences in 1/nT2* were examined, in addition to correlations with measures of psychopathology and cognition. Individuals with SZ showed greater 1/nT2* (iron index) compared to HCs in the thalamus (p < 0.01, FWE corrected). Age-related 1/nT2* accumulation was noted in regions of the basal ganglia, coinciding with prior work, and prominent sex-differences were noted in the caudate and thalamus (p < 0.01, FWE corrected). No significant relationship was observed between 1/nT2* and measures of neurocognition or psychopathology. Overall, our findings characterize a non-invasive proxy measure of tissue iron in SZ and highlight thalamic iron accumulation as a potential marker of illness.

Identifiants

pubmed: 35523067
pii: S0022-3956(22)00216-3
doi: 10.1016/j.jpsychires.2022.04.013
pii:
doi:

Substances chimiques

Iron E1UOL152H7

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

272-278

Subventions

Organisme : NCRR NIH HHS
ID : P20 RR021938
Pays : United States
Organisme : NIMH NIH HHS
ID : K23 MH110661
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Susan F Sonnenschein (SF)

Department of Psychiatry, USA.

Ashley C Parr (AC)

Department of Psychiatry, USA.

Bart Larsen (B)

Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.

Finnegan J Calabro (FJ)

Department of Psychiatry, USA; Department of Bioengineering, USA.

William Foran (W)

Department of Psychiatry, USA.

Shaun M Eack (SM)

Department of Psychiatry, USA; School of Social Work, USA.

Beatriz Luna (B)

Department of Psychiatry, USA; Department of Psychology, USA; Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA.

Deepak K Sarpal (DK)

Department of Psychiatry, USA. Electronic address: sarpaldk@upmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH